The Georgian Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Georgian Health Digest.

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

December 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Press releases published on December 2, 2025

December 2, 2025

First U.S. Commercial Sale of KOMZIFTI™ Triggers $135 Million Milestone Payment to Kura Oncology Under Collaboration and License Agreement with Kyowa Kirin

GlobeNewswire

December 2, 2025

DoctorBox Adds Mainz Biomed’s ColoAlert(R) to Its Portfolio

GlobeNewswire

December 2, 2025

Silexion Therapeutics Receives Positive Feedback from German Health Authority on Design of Phase 2/3 Clinical Trial in Pancreatic Cancer

GlobeNewswire

December 2, 2025

Amneal to Participate in Upcoming Investor Conferences

GlobeNewswire

December 2, 2025

Genvor and Tuskegee University Announce Teaming Agreement to Advance Peptide Research and Sustainable Crop Protection Technologies

GlobeNewswire

December 2, 2025

Pelthos Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference

GlobeNewswire

December 2, 2025

Aclarion Appoints Jason Brosniak as Commercial Director to Drive Adoption and Market Expansion in the Eastern U.S.

GlobeNewswire

December 2, 2025

Science 37 Receives 2025 Clinical Trials Arena Site Innovation Award for R&D Leadership

GlobeNewswire

December 2, 2025

Amneal Receives U.S. FDA Approval for Albuterol Sulfate Inhalation Aerosol

GlobeNewswire

December 2, 2025

Alkeus Pharmaceuticals Appoints Renowned Retina Specialist and Biotech Executive Carlos Quezada-Ruiz, M.D., F.A.S.R.S., as Chief Medical Officer

GlobeNewswire

December 2, 2025

Predictive Oncology Regains Compliance with Nasdaq's Minimum Stockholders' Equity Requirement

GlobeNewswire

December 2, 2025

Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium

GlobeNewswire

December 2, 2025

Electra Therapeutics Presents SURPASS Pivotal ELA026 Study Design and Highlights the Critical Unmet Need in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) at the ASH 2025 Annual Meeting

GlobeNewswire

December 2, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4

GlobeNewswire

December 2, 2025

Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain

GlobeNewswire

December 2, 2025

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology

GlobeNewswire

December 2, 2025

Three Trailblazing Women in Health Care Honoured with the Medal of the Member of the National Assembly

GlobeNewswire

December 2, 2025

Trois femmes pionnières en soins de santé récompensées par une Médaille de l’Assemblée nationale

GlobeNewswire

December 2, 2025

Clearmind Medicine Advances CMND-100 to Dosing Phase at Hadassah Medical Center in Ongoing Phase I/IIa Clinical Trial for Alcohol Use Disorder

GlobeNewswire

December 2, 2025

Polyrizon Announces Successful Completion of Key Manufacturing Upscaling Milestone for Its Nasal Spray Platform

GlobeNewswire